Cosmetic Advertising Regulations

Advertising

What is Advertising?

The Advertising Standards Authority (ASA)'s definition of “advertising and advertisement” means any message, the content of which is controlled directly or indirectly by the advertiser, expressed in any language and communicated in any medium with the intent to influence the choice, opinion or behaviour of those to whom it is addressed.

The Advertising Standards Authority (ASA) also provide a Therapeutic and Health Advertising Code which more specifically applies to advertising regulations for products and services available from a healthcare professional. The Therapeutic and Health Advertising Code applies to your clinic, any healthcare professional that works there, the goods you sell and any health services you provide.

Types of Advertising

The list below is by no means exhaustive but shows the types of advertising typically used by aesthetic practitioners to advertise and promote themselves or their clinics and must now abide by all existing and new regulations.

• TVC's / Cinema advertising
• Trade display / stand materials
• Magazine advertising and advertorials including CWH catalogues
• Radio advertising
• Product labels (for claims)
• Press Releases
• Sales team materials whether for selling to or education of retailers
• Point of sale material
• Print materials e.g. patient, consumer leaflets, brochures
• Digital advertising e.g. Ad-Words, web banners, Medium Rectangle Ads (MREC), Online Video (OLV), etc
• Social media posts - Facebook, Instagram, Linked-in, Tik-Tok, X (Twitter) Hashtags
• Websites - own and trade websites including advertorials and any copy content on your products
• Letters and emails to customers concerning treatments other than commercial information
• Influencer posts

Regulation and Governance

Who makes the Regulations?

The New Zealand Government creates all regulations that apply to advertising therapeutic products and services in New Zealand.

Who provides advice and guidance on the Regulations?

Advice and guidance on the regulations is available from Medsafe, the Advertising Standards Authority (ASA), the Therapeutic Advertising Pre-vetting Service (TAPS), and the Medical Council of New Zealand.

Who enforces the Regulations?

Enforcement of the regulations is carried out by Medsafe, the Advertising Standards Authority (ASA), the Medical Council of New Zealand, and the Commerce Commission New Zealand.

What are the penalties?

Section 20 of the Medicines Act 1981 (Restrictions on sale or supply of new medicines), sub-section(2) states:

No person shall —
• sell; or
• distribute by way of gift or loan or sample or in any other way; or
• advertise the availability of —
any medicine to which this section applies before the consent or provisional consent of the Minister to the distribution of the medicine has been given by notice, or otherwise than in accordance with such conditions as may be imposed by the Minister on giving his or her consent or provisional consent and set out in the notice.

Penalties for breaching the regulations are listed in Section 20 of the Medicines Act 1981 (Restrictions on sale or supply of new medicines) sub-section(4), which states:

A person who contravenes subsection (2) commits an offence, and is liable on conviction —
• in the case of an individual, to imprisonment for a term not exceeding 6 months or a fine not exceeding $20,000:
• in the case of a body corporate, to a fine not exceeding $100,000.

Who do I report a breach to?

You can report any breaches in the regulations to: Clinical Aesthetic Network New Zealand (CANNZ), the Advertising Standards Authority (ASA), New Zealand Society of Cosmetic Medicine (NZSCM), New Zealand Aesthetic Nurses Association, Medsafe, the Nursing Council of New Zealand, the New Zealand Dental Association, the Medical Council of New Zealand, the Paramedic Council of New Zealand, or the Pharmacy Council of New Zealand.

What happens if someone reports me?

The Advertising Standards Authority (ASA) will discuss the complaint with you or Medsafe and will send you a letter that you need to respond to in a timely manner. Please remember to engage politely and openly with them. All complaints to the Advertising Standards Authority (ASA) are published on their website regardless of the outcome (the name of complainant is not generally published). Complaints to Medsafe are not published unless prosecution occurs, this will then be in the public arena via the court system.

Prescription Medicines

All advertising and promotional material using any brand names for any medicinal purposes need to comply with the advertising regulations. This includes anti-wrinkle medicine, e.g. Botox, etc, and fat dissolving medications.

For your convenience we have provided both short and long mandatory information for you to copy and include in your advertising material in the Mandatory Information section below. Click the logos above to be taken directly to a brands mandatory information. We also provide generic botulinum toxin mandatory information which can be used when advertising generic botulinum toxin products or branded products that do not publish their own mandatory information.

Branded vs Unbranded (Botulinum Toxin)

Approved and Unapproved Uses (Botulinum Toxin)

You may only advertise prescription medications for approved uses. In the case of Botulinum Toxin, only upper facial rhytids, forehead lines, crows fee and Glabellar lines are approved.

Botulinum Toxin may also be advertised to treat chronic migraine and hyperhidrosis provided they are accompanied by the required mandatory information.

Unapproved Medicines

Unapproved medicines CANNOT be advertised anywhere including social media platforms.

Non-prescription Medicines

Care is needed not to compare the effects of cosmetic product/device/procedure with prescription medicines (botulinum toxin injections), or medical devices (dermal fillers) and methods of treatment like liposuction.

Prescription medicines, medical devices and methods of treatment all have therapeutic purposes. By comparing a cosmetic product to such products, you are implying a therapeutic purpose and only registered medicines or medical devices and methods of treatment can have a therapeutic purpose. Therefore, any non-prescription cosmetic product advertising with such comparisons would breach Section 20 of the Medicines Act 1981 (Restrictions on sale or supply of new medicines).

Platelet Rich Plasma (PRP)

Platelets and plasma are both general sales medicines. Platelet Rich Plasma (PRP) is a non-approved medicine, i.e. not registered by Medsafe, and therefore has no approved therapeutic purpose. Platelet-Rich Plasma (PRP) therapy is a treatment which involves taking a sample of one's blood, spinning it down, and injecting the plasma back into the soft tissue of the chosen site. It is seen by Medsafe as autologous (obtained from the same individual). Because it's autologous it can be administered by a healthcare professional to a patient from whom it was extracted under Section 29 of the Medicines Act 1981 (Exemption for medicine required by medical practitioner). Claims as to the benefits and therapeutic purpose of the procedure CANNOT be made as these would contravene Section 20 of the Medicines Act 1981 (Restrictions on sale or supply of new medicines). It is doubtful as to whether the procedure itself can be advertised.

Medical Devices

What is a Medical Device

• Any device, instrument, apparatus, appliance, or other article that —
• is intended to be used in, on, or for human beings for a therapeutic purpose; and
• does not achieve its principal intended action in or on the human body by pharmacological, immunological, or metabolic means (but may be assisted in its function by such means)

Advertising Medical Devices

All advertising and promotional material using a medical device brand name must comply with the advertising regulations, i.e. fillers & skin boosters, and biostimulators.

If you use the brand name of any aesthetic or cosmetic medical devices in any form of advertising or promotional material targeting consumers, you must include the appropriate consumer mandatory information for that brand. For your convenience we have provided both short and long mandatory information for you to copy and include in your advertising material in the Mandatory Information section below. Click any of the logos above to be taken directly to their consumer mandatory information.

Polydioxanone Sutures (PDO) Threads

Medsafe concerning PDO Threads — “These may be medical devices but it depends on exactly what the advertiser claims for them. Sometimes actions are claimed that could only be performed by a medicine. Note that presence on the Web Assisted Notification of Devices (WAND) does not confirm that a product is definitely a medical device.”

In order to have any promotional materials approved by Therapeutic Advertising Pre-vetting Service (TAPS), a WAND for the product must be supplied with the item.

Advertising Rules

Wording of Claims

Botulinum Toxin Products (Prescription Medicine)

Claims around the anti-wrinkle properties of botulinum toxin can be made for both branded and unbranded consumer or HCP advertisements. This must be consistent with the datasheets for all the botulinum toxin brands.

Claims to be anti-ageing are NOT in line with the approved uses of botulinum toxin products (or unbranded terms such as anti-wrinkle injections). You can talk about reducing the visible signs of ageing such as wrinkles, or reducing the visibility of wrinkles, or similar wording. The effects of ageing on the face can be discussed in an advertisement/promotional item, however, care should be taken not to imply the products are in any way anti-ageing.

Dermal Filler Products (Medical Devices)

Claims for dermal fillers are set out in the product's Web Assisted Notification of Devices (WAND) on the Medsafe website.

The WAND database content is only accessible by the product sponsor (e.g. Allergan Aesthetics, Galderma, etc). Therefore aesthetic/cosmetic clinics need to obtain a copy of the WAND before generating any advertising/promotional materials.

In order to have any promotional materials approved by Therapeutic Advertising Pre-vetting Service (TAPS) for an aesthetic/cosmetic medicine registered as a medical device, the WAND for the product must be supplied. Ask the supplier of the medical device for the WAND details.

Alternative Words or Phrases

Alternative words or phrases for botulinum toxin such as anti-wrinkle injections, wrinkle relaxer injections, dermal filler injections, double chin injections, does NOT circumvent the advertising regulations. You now need to show mandatory information when using these terms even though they are not brand names.

Media such as photos and video showing injections into the lips to increase volume (lip flip) on websites, social media platform, etc, also contravene Section 20 of the Medicines Act 1981 (Restrictions on sale or supply of new medicines) and risk action from Medsafe.

Comparative Advertising

The Advertising Standards Authority (ASA) Therapeutic and Health Advertising Code states:

• Comparative advertising shall be balanced and shall not be misleading, or likely to be misleading, either about the product, device or service advertised or classes of products, devices or services, with which the comparison is made.
• Comparative advertisements shall not be disparaging and shall be factual, fair and able to be substantiated, referenced to the source and reflective of the body of available evidence.
• Comparative advertisements shall not discourage consumers from following the advice of their healthcare practitioner.

Comparative advertising is a very difficult area that is full of risks especially for clinics as you need to consider a whole raft of laws, regulations, and codes. Whilst comparing the performance of products is allowed the level of proof required needs to be very high and held on file by your clinic. Advertising material from a manufacturer or supplier is not considered sufficient proof to support any claims. The recommendation is to consult with professionals such as Therapeutic Advertising Pre-vetting Service (TAPS) when engaging in an advertising campaign that includes comparative claims.

Before & After Images or Videos

You must exercise caution when including any images or video in your advertising, particularly “before and after” images or video. These can have a significant potential to mislead or deceive, to give the impression or create an expectation of a successful outcome, and to encourage unnecessary use of a service. If you use “before and after” images or videos you must ensure that they:

• are there solely for the purpose of providing accurate and useful information to patients
• portray a realistic outcome that patients could expect
• only feature patients who have undergone the advertised procedure while under your or your clinics care
• have not been altered in any way
• use the same lighting, contrast, background, framing, camera angle, exposure and other photographic techniques in both the “before” and “after” views
• are consistent in appearance including posture, clothing and make-up
• are only used when the patient featured has given their full informed consent
• Include the qualifier — Individual results may vary.

In addition, any full face photos or videos are considered to be a testimonial if the patient is identifiable so it is now insufficient to only cover or blur the eyes, you may only show a cropped part of the face. Even if the media is directed towards other healthcare professionals you must still conceil the identity of the subject.

Before and after images and videos depicting non-approved uses CANNOT be used in advertising or promotional material. Additional information can be found in Section 58 of the Medicines Act 1981 (Further restrictions on advertisements) or the Medical Council Current Standards.

Client Identification = Testimonial

When advertising services offered by you or your clinic on a website or social media platform, you need to be careful to conceil the identity of any patient. Clearly identifiable patients undergoing a procedure such as anti-wrinkle injection treatment or dermal fillers in videos or images is considered a testimonial which contravenes the Medicines Act 1981. The patient should not be identifiable in the image or throughout the entire video promotion.

Testimonials and Reviews

What is a Testimonial

A testimonial can include any of the following from patients, colleagues, other health professionals, friends, or family:

• A statement of the benefits from the care provided.
• A recommendation or positive statement made by a person about a medical practitioner's care, skill, expertise, or treatment.
• A character reference.
• An expression of appreciation.

You CANNOT solicit a testimonial from your clients and any testimonial provided CANNOT include any of the following:

• Any treatment where a prescription medicine or medical device was used.
• A clients social media post re-shared on any of you or your clinics social media platforms.
• You or your clinic being "tagged" in any of your clients posts depicting their treatment.

Testimonials are NOT allowed for prescription medicines (i.e. botulinum toxin products), or medical devices (i.e. dermal fillers). Section 58 of the Medicines Act 1981 (Further restrictions on advertisements) states:

• Subject to section 60 of this Act, no person shall publish, or cause or permit to be published, any medical advertisement that —
• directly or by implication claims, indicates, or suggests that a medicine of the description, or a medical device of the kind, or the method of treatment, advertised —
• has beneficially affected the health of a particular person or class of persons, whether named or unnamed, and whether real or fictitious, referred to in the advertisement

Patient Experiences

Patient experience can be used in advertising or promotional materials e.g. Online Video (OLV), provided:

• The patient experience describes their present situation and having to put up with or live with such things as frown lines and a sagging complexion, i.e. this is the present tense.
• They can describe the problems or irritations of living with frown lines and a sagging complexion and the social reasons that they would like to have this fixed.
• Patients can talk about their aspirations for the future, this is essentially what they would like to happen. It is strongly recommended to make use of the future tense as safeguard.

Do NOT use videos or images of a patient being injected with any aesthetic/cosmetic medicine by a healthcare professional to illustrate the patient's experience as this could be interpreted as a healthcare professional endorsement and patient testimonial for a prescription medicine or medical device. If you are thinking of doing patient experience advertising, please make sure you approach a Therapeutic Advertising Pre-vetting Service (TAPS) adjudicator for advice during concept development.

Professional Endorsements

Professional endorsements are NOT allowed for prescription medicines (i.e. botulinum toxin products), or medical devices (i.e. dermal fillers). Section 58 of the Medicines Act 1981 (Further restrictions on advertisements) states:

• Subject to section 60 of this Act, no person shall publish, or cause or permit to be published, any medical advertisement that —
• directly or by implication claims, indicates, or suggests that a medicine of the description, or a medical device of the kind, or the method of treatment, advertised  —
• is or has been used or recommended by a practitioner, nurse, or pharmacist, or by any other person qualified to provide therapeutic treatment in the course of a profession or occupation and registered under any enactment as a person so qualified, or by a person who is engaged in study or research in relation to any of those professions or occupations or the work performed by persons employed therein

If you are thinking, of doing patient experience advertising, please make sure you approach a Therapeutic Advertising Pre-vetting Service (TAPS) adjudicator for advice during concept development.

Reviews on Social Media

Clients must not be asked to submit reviews on any platforms for any cosmetic/aesthetic procedures. Where possible reviews should be switch off on any platforms you or your clinic have a presence.

You and your clinic are regarded by the law as the owners of all the content on your website and social media pages. Under the self-regulatory model of advertising run in New Zealand, you are responsible for removing all comments on your website or posted on social media pages that are in breach of either the Medicines Act 1981 or the Therapeutic and Health Advertising Code or the Fair Trading Act 1986.

Influencer and Client Posts on Social Media

When is a social media post considered an advertisement? When offering free products or services, or the intention is to promote your clinic or the services it provides. When posting content on your own website or any of your social media platforms you control what is posted and you can adhere to the rules and guidelines, however, there are also rules for any client's or influencer's who post to their own social media platforms:

• You cannot share a client's post.
• Your client cannot tag you or your clinic on their posts.
• You cannot allow a client to post a photo of you treating them.
• Influencers must not share with the public any of their treatments with a prescription medicine or medical device or their assessment of the performance of any treatment.
• A post must be marked as an advertisement if any payment, free service or product was given.
• Advertisements by influencers need to follow the same guidance as for customer feedback. In addition, the nature of the agreement between the influencer and advertiser needs to be declared on the advertisement. The Advertising Standards Authority (ASA) recommends the labels “Ad”, “Advert” or “Advertisement” with or without hashtags, as the clearest way of labelling advertising content.
• Hashtags - All links on any advertisement or social media post must adhere to the rules this includes any hashtags.

Gifts, Giveaways and Discounts

Gifts, giveaways, prize draw or discounts for prescriptions medicines, e.g. botulinum toxin products, or medical devices, e.g. dermal fillers, CANNOT be offered. It is recommended that you make very clear that any gift, giveaway, prize draw or discount offered by a clinic does not include any prescription medicine or medical device as part of the promotion.

The Medical Council Statement on Advertising states in “Offering discount coupons, gift certificates, online deals and vouchers”:

• If you offer inducements such as discount coupons, online deals and vouchers or gift certificates, you must ensure that they do not undermine your relationship with the patient and the informed consent process. In particular, you must make it clear that:
• buying the deal, coupon or certificate does not equate to informed consent from the patient
• you will assess the patient and discuss treatment options before going ahead with any treatment
• the patient has the right to opt out of the treatment at any time
• you will not provide the treatment if your assessment indicates that the patient is not a suitable candidate.
• You should not offer medical assessments or treatments as a prize or gift where your objective is to make money and/or to increase your or your practice's profile.

Examples

Advertising Rule Violations

• Consultations can be free then you can discount any treatment provided there has been an initial consultation.
• The term “appearance medicine” does not require you to provide consumer mandatory information, however, having prescription medicines and terms such as antiwrinkle in the hashtags does require that consumer mandatory information be shown.
• There can be no time constraint on any special offers.

• No advertising of any unapproved uses of Botulinum Toxin products, e.g. Lip Flip, Masseter Botox, Chin or DAO Botox, Platysmal band Botox.
• Only approved uses of Botulinum Toxin can appear in any advertisments or promotions, i.e. upper facial rhytids, forehead lines, crow's feet, and glabellar lines. You may also advertise Botulinum Toxin treatments for chronic migraine and hyperhidrosis.

• Advertising Botulinum Toxin for unapproved uses.
• Using brand names without providing the consumer mandatory information.
• Don't forget, even showing a prescription medicine or medical device brand name in a hastag requires you show consumer mandatory information.

• Needs mandatory consumer information when advertising a brand name prescription medicine.
• Cannot use a photo supplied by the supplier.

• Dermal fillers as a word now needs mandatory consumer information included.
  For unbranded dermal fillers you can use the Generic Dermal Filler consumer mandatory information.

Comparative Advertising

• Comparative advertising is not prohibited but needs to be very carefully considered and crafted.
• Any Terms & Conditions must be made clear and within proximity of the advertisement.
• There needs to be a clear definition of what price will be beaten by a further 10%.
• Discounts are NOT allowed on precription medications or medical devices.

• Same advertisement with additional information included below to clarify pricing and discount.
• It's best to seek the advice of professional services such as Therapeutic Advertising Pre-vetting Service (TAPS) to confirm your advertisement adheres to all advertising laws and guidelines.

• You are NOT allowed to advertise discounts on any precription medicines.

• Packages you offer with no mention of a discount or a limited time are allowed to be advertised.

• The advertising of discounts on prescription medicines and medical devices is not permitted.

• Discounts as a percentage reduction of the overall cost of treatment is allowed, however, any advertisement needs to clearly state this fact.

Before and After Photos

• Patient consent acquired.
• Depicting actual work performed.
• Realistic outcome with no photoshopping or filters.
• Same lighting, framing and camera angle.
• Client is unidentifiable.
• Disclaimer present — Individual results may vary.

• Patient consent acquired.
• Depicting actual work performed.
• Realistic outcome with no photoshopping or filters.
• Same lighting, framing and camera angle.
• Client is unidentifiable.
• Disclaimer present — Individual results may vary.

It is recommended to add a discrete watermark to all your images posted publically to discourage the stealing and misuse by others.

• Videos and images which allow the patient to be clearly identified cannot be used.
  If the person can be identified this is considered a testimonial which contravenes Section 58 of the Medicines Act 1981.
• Just covering the eyes or eyeballs is not considered sufficient to prevent a person from being identified.

• Patient cannot be identified.
• Images highlight only the specific area treated.

Memes

• If a meme mentions any prescription medication or medical device it must include the consumer mandatory information in close proximity.

Testimonials

• Showing a photo of a staff member and a patient both of which are clearly identifiable is considered a testimonial.
• Image of a prescription medicine or medical device with a healthcare professional is considered a professional endorsement and is prohibited.
• Injecting botox into any area not considered as an approved use cannot be depicted in any advertising.

• Staff member is not identifiable.
• Patient is not identifiable.
• Prescription medicine is not being shown and promoted.
• Injecting dermal filler into fine lines is allowed.

• A testimonial from a client about any treatment with a prescription medicine or medical device is not allowed.
• If a client is identifiable in any way, by face, or name, or even social media handle it is considered a testimonial.

• Testimonials limited to staff friendliness and how the customer feels about their time at your clinic are permitted.

• Testimonials posted on social media platforms that include comments on treatments using prescription medicines or medical devices are not allowed.
  (This includes any laser type machines or injectables.)

Services

• It is permitted to advertise the quality of the service your clinic provides, e.g. friendly staff, types of services offered, or machinery and equipment offered to perform treatments.

• It is not acceptable to imply that your clinic or the services it provides are better than your competitors.

What are you allowed to advertise?

• Any non-prescription Skincare products.

• Any beauty treatments such as facials, hair or nail treatments.

• Any feedback, posts or videos by patients must be restricted to comments on the friendliness of staff or the way they made the patient feel about their time at your clinic.

Additional questions

If the eyes are closed does this count as not full-face in any advertising images? No.

Does a laser or other device count as a medical device? Yes.

Do these rules apply to facials? No.

If I have a meme that says BOTOX does this count as an image that needs consumer mandatory information attached? Yes.

Can we be shown actually performing injections? Yes, if both the healthcare professional and the client cannot be identified, otherwise No.

Can we show a needle? Yes.

Mandatory Information

If you use the brand name of any aesthetic or cosmetic medicines that are prescriptions medicines or medical devices in any form of advertising or promotional materials targeting consumers, you must include the appropriate consumer mandatory information for that brand.

• Full Consumer Mandatory Information if the advertisement/promotion contains therapeutic or promotional claims for the product.
• Short Consumer Mandatory Information if the advertisement/promotion does not include any therapeutic or promotional claim and designed only as a brand reminder or when using digital media.

This includes any hashtag, e.g. #botox.

Size and Position of Mandatory Information

• In New Zealand the mandatory information CANNOT be substituted by a hyperlink or QR Code irrespective of the media channel.
• The minimum size of the mandatory information is no longer stated in any legislation or codes, however, this information must be legible. In a digital environment requiring a user to zoom in until it can be read is unlikely to be regarded as acceptable. If the consumer mandatory information cannot be read at 100% zoom on a regular screen size or the screen size that most people will use, e.g. smart phone for Facebook/Instagram, it is unlikely to be considered legible.
• If the content can only be read a few words at a time before having to scroll left or down, then it is unlikely to be considered legible, such as on a smart phone when viewing Facebook/Instagram. There has been a case where it was ruled that although the mandatory information was present on the advertisement, its small size meant that it could not be easily read by a customer. Therefore the mandatory information was considered illegible and treated as if they were not present on the advertisement.
• Mandatory information can be included in the text content of a Facebook or Instagram post.
• Mandatory information can be included as part of an image in a multi-image post such that it can be spread over multiple images that appear in the post to ensure legibility. A single static image post is unlikely to have sufficient space for the mandatory information and brand name or company address, and still ensure legibility.

Medical Device Mandatory Statements

Any machines you use are also medical devices, and you will need to go to your suppliers to get Mandatory Statements.

Association of New Zealand Advertisers (ANZA) For assistance and pre-vetting

What happens if Mandatory Statements are not included?

• The regulator for prescription medicines and medical devices is Medsafe, and they could take action if mandatory information is not included which would contravene the Medicines Act 1981.
• A competitor or member of the public could take a complaint to the Advertising Standards Authority (ASA) if mandatory information is not present and is a requirement as outlined in the ASA Therapeutic and Health Advertising Code
• A competitor could take a complaint to the New Zealand Society of Cosmetic Medicine (NZSCM) or Clinical Aesthetic Network New Zealand (CANNZ) in relation to their Code of Practice if mandatory information is not included.

The direct-to-consumer (DTC) advertising of all Medicines and Medical Devices are regulated by:

• Medicines Act 1981
• The Medsafe Guidelines
• The ASA Therapeutic and Health Advertising Code

Long and Short Manadatory Statements



Belkyra® Prescription Medicine BELKYRA® injection non-surgically reduces fat under the chin, resulting in a more contoured neck profile and jawline. Belkyra® has risks and benefits. Ask your doctor if Belkyra® is right for you. Deoxycholic acid 10mg/ml. For product information check with your doctor or the Consumer Medicine Information on www.medsafe.govt.nz. Allergan (NZ) Limited, Auckland.
BELKYRA® injection is a prescription medicine containing 10mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years. Allergan New Zealand Limited, Auckland.

Belotero® Medical Device Class III to smooth facial wrinkles and folds, correct facial atrophic scars, restore or enhance the lips or restore facial volume Belotero® has risk and benefits. Ask your doctor if Belotero is right for you. For product information check with your doctor or from product details with the supplier. Contains Sodium Hyaluronate Gel. Merz, Sydney. Distributed by Healthcare Logistics, Auckland.
Belotero® is a Class III medical device to smooth facial wrinkles and folds, correct facial atrophic scars, restore of enhance the lips or restore facial volume. Belotero has risk and benefits. Ask your specialist if Belotero® is right for you. Contains transparent cross-linked sodium hyaluronate gel of nonanimal origin with lidocaine 0.3% to reduce local pain. Do not use if you have a skin inflammation or a skin infection or until the infection is healed. Precautions. There is a risk of infection. Tell your doctor if you are on blood-clotting medicines as there could be an increased risk of bruising or bleeding at the injection site. Possible side effects: swelling, bruising, redness hardening of the skin, pain, altered colour or itching. Lasts 6-12 months. You will need to pay for this product and doctor's fees apply. Merz, Sydney. Distributed by Healthcare Logistics, Auckland.

BELOTERO® Revive is an injectable resorbable implant intended to revitalize facial skin through rehydration of dry and very dry skin, improvement of elasticity and firmness, and smoothening of superficial fine lines by reducing skin roughness. Belotero® Revive is indicated for revitalization of early-onset photodamaged facial skin, as characterized by dehydration, loss of elasticity and firmness, and presence of superficial fine lines. You should tell your practitioner and avoid treatment with BELOTERO® Revive if you: have had an allergic reaction to any of the ingredients; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing, inflamed or infected skin, active auto-immune disease or general infection; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, epilepsy, liver or kidney problems, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. Copyright © 2023. Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL) 58 Richard Pearse Drive, Mangere, Auckland 2022. All rights reserved. Belotero® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA.

Botox®, Prescription Medicine for the treatment of frown lines and crow's feet around the eyes. Botox® has risks and benefits. Ask your doctor if Botox® is right for you. Botulinum toxin type A 50, 100, 200 Units. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz. Allergan, Auckland.
Botox® is a prescription medicine containing 100 units of Clostridium Botulinum Type A toxin complex for injection. It is used for the treatment of severe frown lines and associated "crow's feet" around the eyes. It should be administered only by trained medical professionals. Talk to your specialists about the benefits/risks of this procedure in appearance medicine. Cautions: people with neuro-muscular transmission disorders, presence of infection at site of injection, pregnancy and lactation. Possible side effects include headaches, pain, burning sensation or redness at injection site, temporary local muscle weakness including eyelid droop, decreased sensation and nausea. If you have side effects or concerns, talk to your doctor. A charge applies. Allergan Pharmaceutical, Auckland.

Dysport®, Prescription Medicine for the treatment of frown lines and crow's feet around the eyes. Dysport® has risks and benefits. Ask your doctor if Dysport® is right for you. Botulinum toxin type A 300 or 500 Ipsen Units. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz. Click for further details Galderma, Auckland.
Dysport® is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow's feet around the eyes. Dysport® has risks and benefits. Ask your doctor if Dysport is right for you. If you have side effects see your doctor. You will need to pay for Dysport, and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz. Dysport lasts about 4-6 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. Contains 500 units of clostridium botulinum Type A toxin. Galderma (NZ) Limited, Auckland.

e.p.t.q. Lidocaine is a sterile, non-pyrogenic, viscoelastic, colourless, transparent gel composed of cross-linked sodium hyaluronate gel of non-animal origin with 0.3% lidocaine hydrochloride in a physiologic phosphate buffer. e.p.t.q. Lidocaine is an injectable gel (also called a dermal filler) used for the correction of nasolabial folds. e.p.t.q. Lidocaine is produced with hyaluronic acid (HA), the HA of the gel is made from a non-animal source. e.p.t.q. Lidocaine should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for Use before prescribing for full safety information, available from www.xytide.co.nz. Copyright© 2024. Xytide Biotech Pty Ltd. Always read the label and follow the instructions. This medical device must be administered by a Healthcare Professional. New Zealand Sponsor Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036

Botulinum toxin injections are prescription medicines for the treatment of frown lines, horizontal forehead lines and crow's feet around the eyes. Botulinum toxin injections have risks and benefits. Ask your doctor if botulinum toxin injections are right for you. For further information ask your doctor or go to www.medsafe.govt.nz.
Botulinum toxin injections are prescription medicine for the treatment of frown lines, horizontal forehead lines and crow's feet around the eyes. Botulinum toxin injections have risks and benefits. Ask your doctor if botulinum toxin injections are right for you. If you have side effects, see your doctor. You will need to pay for your botulinum toxin injection and clinic fees will apply. For details on precautions & side effects consult your doctor or go to www.medsafe.govt.nz. Botulinum toxin injections last about 4 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals.

Dermal filler injections are Medical devices for the treatment of loss of volume in the skin. Dermal fillers have risks and benefits. Ask your doctor if dermal filler injections are is right for you. For further information ask your doctor or go to www.medsafe.govt.nz

PDO threads are made from polydioxanone (PDO), a biocompatible polymer which undergoes complete hydrolytic degradation. The barbs, molded along the thread, anchor into the superficial dynamic fat pads under the skin, to reposition tissue for a non-surgical lift. This can aid in reducing the signs of ageing.

JALUPRO® Superhydro is a sterile resorbable injectable solution which acts as a deep biorevitalization treatment of Amino Acids Replacement Therapy, combined with biopeptides and a high concentration of high and low molecular weight hyaluronic acid. JALUPRO® Superhydro aims at supporting deep connective tissue, facial retaining ligaments and retinacular cutis, supporting the restoration of physiological condition. Distributed by EnVogue Skin NZ Pty Ltd. EnVogue Skin Pty Ltd. ABN 98 620 276 762. All brands and product names mentioned are trademarks of their respective holders. Copyright © 2024. All rights reserved.
Jalupro Super Hydro: IMPORTANT INFORMATION: JALUPRO® Superhydro is a sterile resorbable injectable solution which acts as a deep biorevitalization treatment of Amino Acids Replacement Therapy, combined with biopeptides and a high concentration of high and low molecular weight hyaluronic acid. JALUPRO® Superhydro aims at supporting deep connective tissue, facial retaining ligaments and retinacular cutis, supporting the restoration of physiological condition, minimising the signs of aging, correcting the imperfections and defect of skin tissue. JALUPRO is composed of a pre filled syringe containing Amino Acids (Glycine, L-Proline, L-Leucine, L-Lysine), biopeptides and 32mg/ml hyaluronic acid. You should not receive treatment with any JALUPRO® SuperHydro product if you are below 18 years of age, if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Distributed by EnVogue Skin NZ Pty Ltd. EnVogue Skin Pty Ltd. ABN 98 620 276 762. All brands and product names mentioned are trademarks of their respective holders. Copyright © 2024. All rights reserved.

Juvederm Ultra™ & Ultra Plus™, Medical Device Class III. For the filling of medium size and deep facial wrinkles by injection into the skin. Juvederm™ has risks and benefits. Ask your doctor if Juvederm™ is right for you. Volume (mL) 0.8mL Volume (mL) 1.0m hyaluronic acid + lidocaine. For product information check with your doctor or from product details with the supplier. Allergan, Auckland.
Juvederm Ultra™ & Juvederm Ultra Plus™ are medical devices Class III for the filling of medium size and deep facial wrinkles by injection into the skin and for creating definition and volume in the lips. Contains 24mg/mL cross-linked hyaluronic acid. Juvederm has risks and benefits. Cautions: Use in an area that has been treated with another dermal filler, people with autoimmune disease, or who are pregnant, breastfeeding, under 18 years of age or have an increased susceptibility to keloid formation and hypertrophic scarring. People on blood thinning medicines. Possible side effects: injection site inflammatory reactions (redness/swelling, itching/pain on pressure) induration or nodules; discolouration; weak filling effect. If you have side effects or concerns speak to your doctor. Product and treatment costs will apply. Note: Juvederm treatment lasts about 12-24 months. For product information check with your doctor or product information at Allergan (NZ) Limited, Auckland.

MINT™ stands for "Minimally Invasive Non-surgical Thread". The threads are made from polydioxanone (PDO), a biocompatible polymer which undergoes complete hydrolytic degradation. The barbs, molded along the thread, anchor into the superficial dynamic fat pads under the skin, to reposition tissue for a non-surgical lift. This can aid in reducing the signs of ageing. Distributed by Mondeal Pty Ltd.

Profhilo® Medical Device Class III. For the redefinition and laxity remodelling where skin laxity is a problem. Profhilo has risks and benefits. Contains low & high molecular weight hyaluronic acid (64mg/2ml). Ask your doctor if Profhilo is right for you. For product information check with your doctor or from product details with the Distributor Healthcare Logistics, Auckland.
Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo® has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

Radiesse® injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands. Radiesse® injectable implant is indicated for: the treatment of nasolabial folds, marionette lines or jawline; the augmentation of cheeks; the hand augmentation to correct volume loss in the dorsum of the hands; and the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. Radiesse® (+) Lidocaine injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands in adults. Radiesse® (+) Lidocaine injectable implant is indicated for: the treatment of nasolabial folds, marionette lines and jawline; the augmentation of cheeks; hand augmentation to correct volume loss in the dorsum of the hands; the restoration and/or correction of the signs of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands fat loss (lipoatrophy) in people with human immunodeficiency virus. You should tell your practitioner and avoid treatment with Radiesse®/Radiesse® (+) Lidocaine if you: have had an allergic reaction to any of the ingredients or have severe allergies including anaphylaxis; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing; inflamed or infected skin; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, tumors, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. Merz Australia Pty Ltd (ACN: 151 073 559) Sydney, Australia. NZ Distribution: Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022. For more information please phone 0800 822 310.

Restylane®, Medical Device Class III to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane® has risk and benefits. Ask your doctor if Restylane® is right for you. For product information check with your doctor or from product details with the supplier. Stabilised Hyaluronic Acid 20mg/ml. Galderma, Australia, Sydney or distributor Healthcare Logistics, Auckland.
Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a nonresorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland.

Restylane® Skinboosters Medical Device Class III. For the treatment of skin structure, hydration and elasticity. Restylane Skinboosters has risks and benefits. Ask your doctor if Restylane Skinboosters is right for you. 20mg/ml stabilised hyaluronic acid. For product information check with your doctor or from product details with the supplier. Galderma Australia Sydney or distributor Healthcare Logistics, Auckland.
Restylane® Skinboosters is a gel containing hyaluronic acid that is injected into or below the skin to improve skin structure, hydration and elasticity. Restylane® Skinboosters is a medical device class III that has risks and benefits. Do not use in patients with bleeding disorders, or in patients taking blood thinning medicines. Do not inject intravascularly, where there is active disease, inflammation, infection, or tumours near the intended treatment site. Possible side effects are injection site effects like swelling, bruising, and tenderness and inflammation. Treatment usually lasts 6-12 months. Product and treatment costs will apply. Consult your cosmetic practitioner for further information. Further product details can also be found in the full product information. Galderma, Auckland.

Sculptra® Medical Device Class III to increase volume of depressed areas, particularly to correct skin depressions. Sculptra has risks and benefits. Contains Poly-L-Lactic acid implant suspension. Ask your doctor if Sculptra® is right for you. For product information check with your doctor or from product details with the supplier. Galderma Australia Sydney. Distributed by Healthcare Logistics, Auckland.
Sculptra® is a poly-L-lactic acid implant liquid that is injected by a healthcare professional into or below the skin to increase volume of depressed areas, particularly to correct skin depressions. Class III Medical Device. Sculptra® may also be used for large volume restoration and/or correction of the signs of facial fat loss. Sculptra® has risks and benefits. Sculptra® treatment may result in injection site reactions and pain. Ask your healthcare professional to explain the range of possible side effects and tell them if any side effects concern you. Sculptra® should not be injected into skin that is inflamed or infected. Exposure to excessive sunlight or UV lamp exposure should be avoided until redness or swelling has resolved. Sculptra® is not recommended for people taking blood thinning medicines and has not been tested in pregnant or breast-feeding women or those aged under 18 years. Lasts for 12-25 months. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma Australia, Sydney. Distributed by Healthcare Logistics Auckland.

STYLAGE® S Lidocaine (16mg/mL), STYLAGE® M Lidocaine™ (20mg/mL), STYLAGE® L Lidocaine™(24mg/mL), STYLAGE® XL Lidocaine™(26mg/mL), STYLAGE® XXL™(21mg/mL), and STYLAGE® Lips Plus are hyaluronic acid injectable gel classified as medical devices Class III for the filling of medium size and deep facial wrinkles by injection into the skin and for redefining lip and/or augmenting lip volume. Contains transparent cross-linked sodium hyaluronate gel of non-animal origin with lidocaine 0.3% to reduce the pain associated with the injection. Cautions: people with autoimmune disease, or who are pregnant, breastfeeding, under 18 years of age or have an increased susceptibility to keloid formation and hypertrophic scarring. People on blood thinning medicines. Possible side effects: injection site inflammatory reactions (redness/swelling, itching/pain on pressure) induration or nodules; discolouration. You will need to pay for this product and doctor’s fees apply. If you have side effects or concerns speak to your practitioner. Distributed by EnVogue Skin NZ Pty Ltd. EnVogue Skin Pty Ltd. ABN 98 620 276 762. All brands and product names mentioned are trademarks of their respective holders. Copyright © 2023. All rights reserved.

STYLAGE® Lips Plus (20mg/mL) IPN-Like Cross-linked Hyaluronic acid gel of non-animal origin with Mannitol and 0.3% Lidocaine is classified as medical devices Class III specially indicated for redefining lip and/or augmenting lip volume. Only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. Always read and follow the instructions. If you have side effects or concerns speak to your practitioner. Distributed by EnVogue Skin NZ Pty Ltd. EnVogue Skin Pty Ltd. ABN 98 620 276 762. All brands and product names mentioned are trademarks of their respective holders. Copyright © 2023. All rights reserved.

Sunekos containing hyaluronic acid and amino acids is a class III medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. Sunekos has risks and benefits. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammation or irritation in the area to be treated; or in patients predisposed to coagulation disorders. A local reaction may rarely occur, caused by hypersensitisation phenomena, with symptoms that include oedema and sensation of burning and/or itching. These reactions normally resolve within two days. Consult your healthcare professional to see if Sunekos is right for you. For more information refer to the instructions for use. New Zealand Sponsor: AA-Med Pty Ltd. Distributed by: Xytide Biotech NZ Pty LTD.
Sunekos 1200 is an implantable medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. It is suitable for creating a temporary increase in the volume of skin tissue. Sunekos 1200 is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids. Sunekos Performa is a medical device recommended for the treatment of blemishes and depressions in the skin caused by wrinkles and scars. Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for use before prescribing for full safety information, available from www.xytide.co.nz New Zealand Sponsor: AA-Med Pty Ltd Distributed by: Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036.

Teosyal® from Teoxane® Medical Device Class III is a space-occupying supplement to correct skin contour deformities (e.g. wrinkles, folds, scars especially around the eyes). Teosyal® has risks and benefits. Contains Hyaluronic Acid in various volumes with lidocaine 0.3% by mass. Ask your doctor if Teosyal® is right for you. For product information check with your doctor or from the supplier. Distributed by Healthcare Logistics Auckland.
TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS®, TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP TEOSYAL KISS®, RHA KISS®, TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademarks of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride. They are class III medical devices. Caution for people on blood thinning medicines. Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in skin and hair, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke. Lasts 9-12 months. Please consult your doctor pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

Xeomin® (incobotulinum toxin) Prescription Medicine for the treatment of upper facial lines: glabellar frown lines, crow's feet round the eyes, horizontal forehead lines. Xeomin® has risks and benefits. Ask your doctor if Xeomin® is right for you (incobotulinum toxin A, purified Botulinum toxin type A 50 Units and 100 Units). For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz. Merz, Sydney. Distributed by Healthcare Logistics, Auckland.
Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection. It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin® treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. Treatment last for up to 4 months. You will need to pay for this medicine. Discuss with your specialist if Xeomin® is right for you. For more information or for a copy of CMI please contact the NZ distributor: Merz, Sydney. Distributed by Healthcare Logistics, Auckland.